Lukaku Medical Ltd SC759895 false 2023-02-23 2024-02-28 2024-02-28 The principal activity of the company is Medical Activities Digita Accounts Production Advanced 6.30.9574.0 true SC759895 2023-02-23 2024-02-28 SC759895 2024-02-28 SC759895 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-28 SC759895 bus:Micro-entities 2023-02-23 2024-02-28 SC759895 bus:AuditExemptWithAccountantsReport 2023-02-23 2024-02-28 SC759895 bus:FilletedAccounts 2023-02-23 2024-02-28 SC759895 bus:SmallCompaniesRegimeForAccounts 2023-02-23 2024-02-28 SC759895 bus:RegisteredOffice 2023-02-23 2024-02-28 SC759895 bus:Director1 2023-02-23 2024-02-28 SC759895 bus:PrivateLimitedCompanyLtd 2023-02-23 2024-02-28 SC759895 countries:AllCountries 2023-02-23 2024-02-28 iso4217:GBP xbrli:pure

Registration number: SC759895

Lukaku Medical Ltd

Unaudited Filleted Financial Statements

for the Period from 23 February 2023 to 28 February 2024

 

Lukaku Medical Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

Lukaku Medical Ltd

Company Information

Director

Dr Mohanad Abdoun

Registered office

4/3
65 Renfield Street
Glasgow
Lanarkshire
G2 1LF

Accountants

GF Sheridan Accountants Ltd
40 Helensburgh Drive
Glasgow
Lanarkshire
G13 1RS

 

Lukaku Medical Ltd

(Registration number: SC759895)
Balance Sheet as at 28 February 2024

2024
£

Fixed assets

1,437

Current assets

114,340

Creditors: Amounts falling due within one year

(46,576)

Net current assets

67,764

Total assets less current liabilities

69,201

Accruals and deferred income

(1,300)

 

67,901

Capital and reserves

67,901

1

General information

The address of its registered office is:
4/3
65 Renfield Street
Glasgow
Lanarkshire
G2 1LF
Scotland

These financial statements were authorised for issue by the director on 2 April 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 2.

For the financial period ending 28 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

 

Lukaku Medical Ltd

(Registration number: SC759895)
Balance Sheet as at 28 February 2024

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 2 April 2024
 

.........................................
Dr Mohanad Abdoun
Director